Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4M Buy
19,066
+1,539
+9% +$387K 0.03% 410
2025
Q4
$4.98M Buy
17,527
+835
+5% +$261K 0.04% 333
2025
Q3
$5.15M Buy
16,692
+158
+1% +$49.5K 0.04% 317
2025
Q2
$5.19M Buy
16,534
+527
+3% +$152K 0.04% 319
2025
Q1
$4.2M Buy
16,007
+441
+3% +$119K 0.04% 340
2024
Q4
$4.06M Sell
15,566
-158
-1% -$39.8K 0.04% 362
2024
Q3
$3.66M Sell
15,724
-137
-0.9% -$28.1K 0.04% 382
2024
Q2
$3.2M Buy
15,861
+250
+2% +$45.1K 0.03% 396
2024
Q1
$2.68M Buy
15,611
+145
+0.9% +$27K 0.03% 440
2023
Q4
$3.36M Sell
15,466
-1,346
-8% -$231K 0.04% 351
2023
Q3
$2.68M Buy
16,812
+949
+6% +$212K 0.04% 380
2023
Q2
$4.57M Buy
15,863
+380
+2% +$115K 0.06% 265
2023
Q1
$4.94M Buy
15,483
+6,125
+65% +$1.82M 0.07% 251
2022
Q4
$2.75M Buy
9,358
+1,148
+14% +$317K 0.04% 364
2022
Q3
$1.88M Buy
8,210
+41
+0.5% +$10.3K 0.04% 401
2022
Q2
$1.78M Buy
8,169
+600
+8% +$136K 0.04% 401
2022
Q1
$2.02M Buy
7,569
+6
+0.1% +$1.47K 0.03% 373
2021
Q4
$2.01M Buy
7,563
+154
+2% +$44.7K 0.03% 382
2021
Q3
$2.11M Sell
7,409
-278
-4% -$79.3K 0.04% 338
2021
Q2
$2.11M Buy
7,687
+831
+12% +$226K 0.04% 353
2021
Q1
$1.79M Buy
6,856
+58
+0.9% +$15.5K 0.04% 338
2020
Q4
$1.74M Sell
6,798
-44
-0.6% -$10.9K 0.04% 338
2020
Q3
$1.62M Buy
6,842
+303
+5% +$63.8K 0.04% 321
2020
Q2
$1.27M Buy
+6,539
New +$1.25M 0.03% 335

Other funds holding PODD

Xponance's PODD Position: Q1 2026 in Review

Xponance increased its Insulet (PODD) stake by 8.8% in Q1 2026, buying an estimated $387K and bringing the position to 19,066 shares worth $4M. The position accounts for 0.03% of the portfolio, ranked #410.

Xponance first reported a position in PODD in Q2 2020 and has held it in 24 quarters since. The position peaked at $5.19M in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Xponance held 19,066 shares of Insulet worth $4M as of Q1 2026.
  • Xponance bought 1,539 Insulet shares in Q1 2026, an estimated $387K.
  • Insulet made up 0.03% of Xponance's portfolio in Q1 2026, its #410 holding.
  • Xponance first reported a position in Insulet in Q2 2020 and has held it in 24 quarters since.
  • Xponance's Insulet position peaked at $5.19M in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.